Peter Yu

6PUBLICATIONS
61CO-AUTHORS
Molecular targetsCancer geneticsGene and molecular therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 23, 2026
Intron retention regulates STAT2 function and associates with immunotherapy response in lung cancer.

|Jul 23, 2026
Development of a clinical trial knowledge management application for community oncology.

|Nov 18, 2025
Phase Ia/b Multicenter Study of BPM31510IV Targeting Mitochondrial Metabolism/Warburg Effect as Monotherapy and Combination Chemotherapy in Solid Tumor Patients.

Vivek Subbiah, Peter P Yu, Rangaprasad Sarangarajan

|Feb 20, 2024
The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study.

Cecilia A Castellano, Tianyi Sun, Deepak Ravindranathan

|Sep 05, 2019
Challenges in assessing the clinical utility and economic value of immune checkpoint inhibitor therapies of Cancer.

Peter Paul Yu, Omar Eton, Louis P Garrison

Pageof 1

Frequent Collaborators

1 joint publications

Sunny R K Singh

1 joint publications

Stephanie Berg

1 joint publications

Panos Arvanitis

1 joint publications

Talal El Zarif